NHS National Generic Pharmaceuticals Transition 2021_1
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 +1 more |
| Procedure | open |
| OCID | ocds-h6vhtk-02aba8 |
Awards (20)
This procurement was awarded to 20 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | · | · | active |
| Amarox Limited shared | · | · | active |
| Ascend Laboratories UK Ltd shared | · | · | active |
| Aspen Pharma Ireland Limited shared | · | · | active |
| Aspire Pharma Limited shared | · | · | active |
| Aventis Pharma ltd t/a Sanofi shared | · | · | active |
| Brown and Burk UK Ltd shared | · | · | active |
| Day Lewis Medical Ltd shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| Kent Pharma Ltd shared | · | · | active |
| Martindale Pharma shared | · | · | active |
| medac Pharma LLP shared | · | · | active |
| Morningside Pharmaeuticals shared | · | · | active |
| Panpharma UK Limited shared | · | · | active |
| Pfizer Ltd shared | · | · | active |
| Ranbaxy UK shared | · | · | active |
| Selective Supplies Ltd. shared | · | · | active |
| Teva UK Limited shared | · | · | active |
| Thornton and Ross Ltd shared | · | · | active |
| Tillomed Laboratories ltd shared | · | · | active |
description
Transition and 33 % products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months).The total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months).
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 29 Apr 2021 | Contract award notice (F03) | Earlier regulations | 009271-2021 |
more from The NHS Commissioning Board (operating under the name of NHS England)
- Implementation of GP referral pathway to NHS CPCS · £1,700,000 · 12 May 2022
- NHS England and NHS Improvement - Independent Clinical Reviews into Deaths in Custody – South East Health & Justice, Detained Estates · 29 Apr 2022
- Provision of Benchmarking Performance Against the Learning Disability Improvement Standards for NHS Trusts · £800,000 · 18 Mar 2022
- PMO Support for the Cancer Healthcare and AI in Health and Care Programmes · £2,000,000 · 3 Mar 2022
- NHS Framework for the North of England, Branded Medicine · £863,999,552 · 1 Mar 2022
- NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual · £216,078,796 · 22 Feb 2022
- NHS National Generic Pharmaceuticals Wave 13 · £1,637,875,080 · 14 Jan 2022
- Targeted Lung Health Check Programme: External Quality Assurance of Radiologists · £800,000 · 22 Dec 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.